glp-1 off label The Use of Agonists in the Management of Cutaneous Disease | JCAD and support a leaner Rise in Off-Label GLP-1 Prescribing

This is not a medical evaluation your provider confirms everything at your free consultation

The first time I tried to run after pushing that heavy sled was a revealing moment...jello legs are a real thing

Interestingly, the GLP-1 receptor agonist, dulaglutide, and the dual GLP-1 and GIP receptor agonist, tirzepatide, are both characterized by a strong delayed gastric emptying upon a single dose administration, but the effect tends to subside as gastric emptying tachyphylaxis is observed after several weeks of treatment

PD has received consulting fees/honoraria from Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, Boehringer Ingelheim, Mundipharma, Merck Sharp & Dohme, Bayer, Abbott, LVL Medical, and Bastide

Doesn't seem that way but maybe

And when you think about first do no harm, you think about alternatives